CD – 44
The Mechanism of Acton for Adiposano® is not fully understood. A second round of RCT investigation is currently underway to help verify and confirm some of the mechanisms involved. One things that is clear – Adiposano® is affecting the regulation of eWATS “upstream and having a widespread affect on a variety of inflammatory markers.
One theory is that CD-44 receptors are being suppressed or blocked.
CD-44 is an extracellular matric receptor expressed I adipocytes (the fat storing cells in adipose tissue). CD-44’s expression level in the adipose inflammation and with insulin resistance (HOMA-IR) in obesity.
Nutritional management with Adiposano® may block CD-44 leading to decreased pro-inflammatory adipokines, decreased systemic inflammation, decreased adipose tissue accumulation, reduced adipogenesis, and improvement in insulin resistance.